April 10 (Reuters) - CERo Therapeutics Holdings Inc CERO.O:
CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES CRITICAL PATENT APPLICATION ALLOWANCES FROM THE U.S. PATENT OFFICE COVERING COMPANY’S LEAD COMPOUND CER-1236
Source text: ID:nGNE64NCNq
Further company coverage: CERO.O
((Reuters.Briefs@thomsonreuters.com;))